Selected article for: "antiviral therapy and chinese medicine"
Author: Tong, Tong; Wu, Ying-Qi; Ni, Wei-Jian; Shen, Ai-Zong; Liu, Sheng
Title: The potential insights of Traditional Chinese Medicine on treatment of COVID-19
  • Cord-id: p4jxqbt1
  • Document date: 2020_5_24
    • ID: p4jxqbt1
    Snippet: Corona Virus Disease 2019 (COVID-19) broke out in 2019 and spread rapidly around the world. There is still no specific antiviral therapy to the current pandemic. In China, historical records show that Traditional Chinese Medicine (TCM) is effective in prevention and enhancing the resistance to pandemic with unique insights. To fight with COVID-19, National Health and Commission of PRC has recommended some TCM in the guideline, such as HuoxiangZhengqi, LianhuaQingwen ShufengJiedu and XueBijing, a
    Document: Corona Virus Disease 2019 (COVID-19) broke out in 2019 and spread rapidly around the world. There is still no specific antiviral therapy to the current pandemic. In China, historical records show that Traditional Chinese Medicine (TCM) is effective in prevention and enhancing the resistance to pandemic with unique insights. To fight with COVID-19, National Health and Commission of PRC has recommended some TCM in the guideline, such as HuoxiangZhengqi, LianhuaQingwen ShufengJiedu and XueBijing, and actually displayed a remarkable effect in clinical treatment strategic for COVID-19. We review studies to provide an in-depth understanding into the effect of TCM, and also introduce the possible mechanism involved in COVID-19 treatment.

    Search related documents:
    Co phrase search for related documents
    • accumulate experience and acute respiratory: 1, 2
    • acute ards respiratory distress syndrome and lung cell damage: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung injury pathogenesis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lymphocyte infiltration: 1, 2
    • acute ards respiratory distress syndrome develop and lung cell damage: 1
    • acute ards respiratory distress syndrome develop and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute ards respiratory distress syndrome develop and lung tissue: 1, 2, 3, 4
    • acute exacerbation and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute exacerbation and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory and lung cell damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and lung injury pathogenesis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute respiratory and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and luteolin kaempferol quercetin: 1, 2, 3, 4
    • acute respiratory and lymphocyte infiltration: 1, 2, 3, 4, 5, 6, 7
    • lung injury and luteolin kaempferol quercetin: 1, 2
    • lung injury and lymphocyte infiltration: 1, 2, 3